Ozempic shown to reduce drinking in first trial in alcohol-use disorder
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink less alcohol.
Ozempic 'Significantly' Lowered 'Alcohol Craving' in First Clinical Trial, with Those Taking the Drug Drinking 40% Less
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of alcohol consumed when someone on the drug does drink
Ozempic Users Are Drinking Less Alcohol Without Even Trying
In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an unlikely source: a drug best known for treating diabetes and obesity. Semaglutide,
Low-dose semaglutide reduces alcohol consumption and cravings in early trial
Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.
Semaglutide shows promise in reducing cravings for alcohol, heavy drinking
Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.
More Evidence Ozempic Can Curb Alcoholism
"The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder." His team published its findings Feb. 12 in JAMA Psychiatry.
Strongest evidence yet that Ozempic and Wegovy reduce alcohol intake
The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really does help curb drinking
Ozempic’s key ingredient may reduce the desire to drink alcohol
In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.
Monthly Prescribing Reference28d
STEP UP Trial: Significant Weight Loss Observed With Higher Dose Semaglutide
Findings showed semaglutide 7.2mg demonstrated a statistically significant and superior weight loss compared with placebo at week 72. Topline data were announced from a phase 3b trial evaluating ...
Higher max dose guidance for semaglutide offers hope
A new study increases max-dose guidance for semaglutide. This offers hope for those who didn’t reach their weight goals. The ...
Weight loss drug semaglutide may reduce alcohol cravings, heavy drinking and smoking, new study finds
Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
Will This New GLP-1 Drug be More Powerful Than Ozempic?
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.
BioPharma Dive1d
New study offers hints of GLP-1 drugs’ potential in curbing alcohol cravings
A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...
News Medical3d
What's Next for Semaglutide? Beyond Diabetes and Weight Loss
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Goodbye Needles, Hello Convenience: Exploring Compounded Semaglutide
Eden is providing access to a new way for individuals to explore GLP-1 therapy: a compounded semaglutide gummy, available ...